Literature DB >> 35040104

Novel benzimidazole derivatives; synthesis, bioactivity and molecular docking study as potent urease inhibitors.

Ebrahim Saeedian Moghadam1, Abdullah Mohammed Al-Sadi2, Meysam Talebi3, Massoud Amanlou3,4, Mohsen Amini5,6, Raid Abdel-Jalil7.   

Abstract

BACKGROUND: Benzimidazole derivatives are widely used to design and synthesize novel bioactive compounds. There are several approved benzimidazole-based drugs on the market.
OBJECTIVES: In this study, we aimed to design and synthesize a series of novel benzimidazole derivatives 8a-n that are urease inhibitors.
METHODS: All 8a-n were synthesized in a multistep. To determine the urease inhibitory effect of 8a-n, the urease inhibition kit was used. The cytotoxicity assay of 8a-n was determined using MTT method. Molecular modelling was determined using autodock software.
RESULTS: All 8a-n were synthesized in high yield, and their structures were determined using 1H-NMR, 13C-NMR, MS, and elemental analyses. In compared to thiourea and hydroxyurea as standards (IC50: 22 and 100 µM, respectively), all 8a-n had stronger urease inhibition activity (IC50: 3.36-10.81 µM). With an IC50 value of 3.36 µM, 8e had the best enzyme inhibitory activity. On two evaluated cell lines, the MTT cytotoxicity experiment revealed that all 8a-n have IC50 values greater than 50 µM. Finally, a docking investigation revealed a plausible way of interaction between the 8e and 8d and the enzyme's active site's key residues.
CONCLUSION: The synthesized benzimidazole derivatives exhibit high activity, suggesting that further research on this family of compounds would be beneficial to finding a potent urease inhibitor.
© 2021. Springer Nature Switzerland AG.

Entities:  

Keywords:  Benzimidazole; Drug design; Nitrogen heterocycles; Synthesis; Urease inhibitors

Mesh:

Substances:

Year:  2022        PMID: 35040104      PMCID: PMC9114190          DOI: 10.1007/s40199-021-00427-3

Source DB:  PubMed          Journal:  Daru        ISSN: 1560-8115            Impact factor:   4.088


  10 in total

1.  Synthesis, molecular docking and biological evaluation of some benzimidazole derivatives as potent pancreatic lipase inhibitors.

Authors:  Emre Menteşe; Fatih Yılmaz; Mustafa Emirik; Serdar Ülker; Bahittin Kahveci
Journal:  Bioorg Chem       Date:  2017-12-28       Impact factor: 5.275

2.  Synthesis and molecular docking study of some 5,6-dichloro-2-cyclopropyl-1H-benzimidazole derivatives bearing triazole, oxadiazole, and imine functionalities as potent inhibitors of urease.

Authors:  Emre Menteşe; Hakan Bektaş; Bahar Bilgin Sokmen; Mustafa Emirik; Demet Çakır; Bahittin Kahveci
Journal:  Bioorg Med Chem Lett       Date:  2017-05-10       Impact factor: 2.823

3.  Design, molecular docking and synthesis of novel 5,6-dichloro-2-methyl-1H-benzimidazole derivatives as potential urease enzyme inhibitors.

Authors:  Emre Menteşe; Mustafa Emirik; Bahar Bilgin Sökmen
Journal:  Bioorg Chem       Date:  2019-01-28       Impact factor: 5.275

4.  5-Bromo-2-aryl benzimidazole derivatives as non-cytotoxic potential dual inhibitors of α-glucosidase and urease enzymes.

Authors:  Tanzila Arshad; Khalid Mohammed Khan; Najma Rasool; Uzma Salar; Shafqat Hussain; Humna Asghar; Mohammed Ashraf; Abdul Wadood; Muhammad Riaz; Shahnaz Perveen; Muhammad Taha; Nor Hadiani Ismail
Journal:  Bioorg Chem       Date:  2017-03-20       Impact factor: 5.275

5.  Synthesis and urease inhibitory potential of benzophenone sulfonamide hybrid in vitro and in silico.

Authors:  Farida Begum; Noor Barak Almandil; Muhammad Arif Lodhi; Khalid Mohammed Khan; Abdul Hameed; Shahnaz Perveen
Journal:  Bioorg Med Chem       Date:  2019-02-02       Impact factor: 3.641

6.  Novel thiobarbiturates as potent urease inhibitors with potential antibacterial activity: Design, synthesis, radiolabeling and biodistribution study.

Authors:  Hanan Gaber Abdulwahab; Marwa F Harras; Nagwan Galal El Menofy; Amany M Hegab; Basma M Essa; Adli AbdAllah Selim; Tamer M Sakr; Heba S A El-Zahabi
Journal:  Bioorg Med Chem       Date:  2020-09-12       Impact factor: 3.641

7.  Developing new hybrid scaffold for urease inhibition based on carbazole-chalcone conjugates: Synthesis, assessment of therapeutic potential and computational docking analysis.

Authors:  Madiha Kazmi; Imtiaz Khan; Ajmal Khan; Sobia Ahsan Halim; Aamer Saeed; Saifullah Mehsud; Ahmed Al-Harrasi; Aliya Ibrar
Journal:  Bioorg Med Chem       Date:  2019-09-16       Impact factor: 3.641

Review 8.  Benzimidazole drugs and modulation of biotransformation enzymes.

Authors:  J Velík; V Baliharová; J Fink-Gremmels; S Bull; J Lamka; L Skálová
Journal:  Res Vet Sci       Date:  2004-04       Impact factor: 2.534

9.  Metabolic pathways of benzimidazole anthelmintics in harebell (Campanula rotundifolia).

Authors:  Lucie Stuchlíková; Robert Jirásko; Lenka Skálová; František Pavlík; Barbora Szotáková; Michal Holčapek; Tomáš Vaněk; Radka Podlipná
Journal:  Chemosphere       Date:  2016-05-18       Impact factor: 7.086

10.  Synthesis and anti-bacterial activity of some novel 2-(6-fluorochroman-2-yl)-1-alkyl/acyl/aroyl-1H-benzimidazoles.

Authors:  Bobba Venkata Siva Kumar; Sanjay Dashrath Vaidya; Ramanatham Vinod Kumar; Shekar Bhaskar Bhirud; Ramchandra Bhimrao Mane
Journal:  Eur J Med Chem       Date:  2006-03-09       Impact factor: 6.514

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.